Research map: Impact of proton pump inhibitors on clinical outcomes and adverse drug reactions in antiplatelet therapy: A prospective study from an Indian hospital

Back to the article

Papers in this map

  1. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes · Juhani M. Knuuti · 2019 · 7290 citations · Cited by this paper
  2. Integrating Cochrane methodology into medical education: Experience and outcomes · 2026 · Related
  3. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS · Marco Valgimigli · 2017 · 3024 citations · Cited by this paper
  4. Pharmacoepidemiological analysis of antiplatelet drug consumption in outpatient practice · 2025 · Related
  5. 2024 ESC Guidelines for the management of chronic coronary syndromes · Christiaan J. Vrints · 2024 · 2786 citations · Cited by this paper
  6. Author’s response: Rates of successful conceptions according to COVID-19 vaccination status: Data from the Czech Republic · 2025 · Related
  7. Clopidogrel with or without Omeprazole in Coronary Artery Disease · Deepak L. Bhatt · 2010 · 1241 citations · Cited by this paper
  8. Follow-up on test referrals and results: Whose responsibility is it? · 2025 · Related
  9. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials · Francesco Costa · 2017 · 1190 citations · Cited by this paper
  10. Prevalence and predictors of self-medication among adults in Mbeya Urban, Tanzania · 2026 · Related
  11. Oral Antiplatelet Therapy After Acute Coronary Syndrome · Hassan Kamran · 2021 · 130 citations · Cited by this paper
  12. Post-SSRI Sexual Dysfunction (PSSD): A comprehensive review of epidemiology, pathophysiology, and clinical management · 2026 · Related
  13. Dual antiplatelet therapy for secondary prevention of coronary artery disease · Sophie Degrauwe · 2017 · 75 citations · Cited by this paper
  14. Flurbiprofen-induced upper respiratory and ocular adverse effects in a patient having non-cardiac chest pain · 2025 · Related
  15. Gastroprotection in patients on antiplatelet and/or anticoagulant therapy: a position paper of National Association of Hospital Cardiologists (ANMCO) and the Italian Association of Hospital Gastroenterologists and Endoscopists (AIGO) · Maurizio Giuseppe Abrignani · 2020 · 69 citations · Cited by this paper
  16. Feeding tube safety: National guidance is unsafe and must change · 2026 · Related
  17. Similar Efficacy of Proton-Pump Inhibitors vs H2-Receptor Antagonists in Reducing Risk of Upper Gastrointestinal Bleeding or Ulcers in High-Risk Users of Low-Dose Aspirin · Francis K.L. Chan · 2016 · 64 citations · Cited by this paper
  18. Use of nootropics in Alzheimer’s disease: An analysis of regulatory positions and drug policies in the countries of the Commonwealth of Independent States · 2025 · Related
  19. Proton pump inhibitor use and risk for recurrent Clostridioides difficile infection: a systematic review and meta-analysis · Kristin M. D’Silva · 2021 · 63 citations · Cited by this paper
  20. The importance of nutrivigilance in Middle East countries and the necessity for incorporation into pharmacovigilance health authorities’ regulations · 2025 · Related
  21. Long-Term PPI Use: Balancing Potential Harms and Documented Benefits · Loren Laine · 2016 · 54 citations · Cited by this paper
  22. Dual Antiplatelet Therapy in Coronary Artery Disease · Raghav Sharma · 2020 · 47 citations · Cited by this paper
  23. Proton pump inhibitors reduce the long‐term risk of recurrent upper gastrointestinal bleeding: an observational study · Elvira González · 2008 · 37 citations · Cited by this paper
  24. Meta-Analysis of Efficacy and Safety of Proton Pump Inhibitors with Dual Antiplatelet Therapy for Coronary Artery Disease · Safi Ullah Khan · 2019 · 30 citations · Cited by this paper
  25. Trends in cardiovascular and bleeding outcomes in acute coronary syndrome patients treated with or without proton-pump inhibitors during the introduction of novel P2Y12 inhibitors: a five-year experience from a single-centre observational registry · Niels Hoedemaker · 2018 · 23 citations · Cited by this paper
  26. Dual Antiplatelet Therapy in Coronary Artery Disease: Comparison Between ACC/AHA 2016 and ESC 2017 Guidelines · Christopher Nicholas Floyd · 2020 · 19 citations · Cited by this paper
  27. Efficacy and Safety of Proton Pump Inhibitors in Patients With Coronary Artery Diseases Receiving Oral Antiplatelet Agents and/or Anticoagulants: A Systematic Review and Meta-Analysis · Yao-Sheng Shang · 2022 · 15 citations · Cited by this paper
  28. Comparative Risk of Hospitalized Bleeding of P2Y12 Inhibitors for Secondary Prophylaxis in Acute Coronary Syndrome After Percutaneous Coronary Intervention · Arun Kumar · 2022 · 14 citations · Cited by this paper
  29. Drug–Drug Interactions and Their Association with Adverse Health Outcomes in the Older Community-Dwelling Population: A Prospective Cohort Study · John E. Hughes · 2024 · 12 citations · Cited by this paper
  30. The association between proton pump inhibitor use and risk of post-hospitalization acute kidney injury: a multicenter prospective matched cohort study · Yue Zhang · 2023 · 9 citations · Cited by this paper
  31. Safety of Antiplatelet Agents: Analysis of ‘Real-World’ Data from the Italian National Pharmacovigilance Network · Lucia Gozzo · 2017 · 8 citations · Cited by this paper
  32. Study of pattern & distribution of adverse drug reactions in acute coronary syndrome patients in a tertiary care hospital · Manjappa Mahadevappa · 2022 · 5 citations · Cited by this paper
  33. Role of the CYP450 Enzymatic Pathway in Drug Metabolism: Focus on Proton-pump Inhibitors and Antiplatelet Therapy · Ashwani Mehta · 2025 · 2 citations · Cited by this paper
  34. Integrating a Pharmacovigilance and Response Unit Team for a Better Adverse Drug Reaction Reporting and Management: Insights from a Prospective Cross-Sectional Study · Vinodkumar Mugada · 2025 · 2 citations · Cited by this paper

Source: OpenAlex (CC0)